These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

375 related articles for article (PubMed ID: 26056734)

  • 21. Further stratification of patients with multiple myeloma by International Staging System in combination with ratio of serum free κ to λ light chains.
    Xu Y; Sui W; Deng S; An G; Wang Y; Xie Z; Yao H; Zhu G; Zou D; Qi J; Hao M; Zhao Y; Wang J; Chen T; Qiu L
    Leuk Lymphoma; 2013 Jan; 54(1):123-32. PubMed ID: 22712834
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of the Freelite serum free light chain (SFLC) assay with serum and urine electrophoresis/immunofixation and the N Latex FLC assay.
    Sasson SC; McGill K; Wienholt L; Carr A; Brown DA; Kelleher AD; Breit SN; Sewell WA
    Pathology; 2015 Oct; 47(6):564-9. PubMed ID: 26352111
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Detection of serum free light chain and its clinical significance in nonsecretory multiple myeloma].
    Chen HF; Hou J; Yuan ZG; Wang DX; Fu WJ; Chen YB
    Zhonghua Xue Ye Xue Za Zhi; 2008 Feb; 29(2):113-6. PubMed ID: 18681313
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Freelite and Kloneus assays in free light chain measurements in patients with renal impairment.
    Morales-García LJ; Lillo Rodríguez RM; Pacheco-Delgado MS
    Clin Biochem; 2023 Aug; 118():110610. PubMed ID: 37429509
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The Value of sFLC and Serum Calcium in the Diagnosis and Prognosis of Multiple Myeloma Patients].
    Pei XH; Zhang LN; Zhou P; Wang TB; Lian C; Zhang P; Lei PC; Zhu ZM
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Jun; 32(3):794-798. PubMed ID: 38926969
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The cumulative amount of serum-free light chain is a strong prognosticator in chronic lymphocytic leukemia.
    Morabito F; De Filippi R; Laurenti L; Zirlik K; Recchia AG; Gentile M; Morelli E; Vigna E; Gigliotti V; Calemma R; Amoroso B; Neri A; Cutrona G; Ferrarini M; Molica S; Del Poeta G; Tripodo C; Pinto A
    Blood; 2011 Dec; 118(24):6353-61. PubMed ID: 21998207
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum Free Light Chains in Common Variable Immunodeficiency Disorders: Role in Differential Diagnosis and Association With Clinical Phenotype.
    Scarpa R; Pulvirenti F; Pecoraro A; Vultaggio A; Marasco C; Ria R; Altinier S; Compagno N; Firinu D; Plebani M; De Carli M; Matucci A; Vianello F; Vacca A; Spadaro G; Quinti I; Agostini C; Milito C; Cinetto F
    Front Immunol; 2020; 11():319. PubMed ID: 32296413
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Expression and significance of immunoglobulin free light chains in serum and lung tissues from patients with chronic obstructive pulmonary disease].
    Zhang M; Tao HC; Li YQ; Pei HS; Zhu SY; Chen B; Zhou RJ; Zhang MW
    Zhonghua Jie He He Hu Xi Za Zhi; 2013 Dec; 36(12):945-9. PubMed ID: 24503428
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The predictive power of serum kappa/lambda ratios for discrimination between monoclonal gammopathy of undetermined significance and multiple myeloma.
    Bergón E; Miravalles E; Bergón E; Miranda I; Bergón M
    Clin Chem Lab Med; 2005; 43(1):32-7. PubMed ID: 15653439
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The clinical significance of serum free light chain in primary systemic amyloidosis].
    Zhai YP; Song P; Li F; Liu HN; Yu YP; Zhou XG; Shi P; An ZM; Zhou X; Zhang CN
    Zhonghua Nei Ke Za Zhi; 2011 May; 50(5):404-7. PubMed ID: 21624224
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Test of Serum Free Light Chain and Its Clinical Significance in Light Chain Multiple Myeloma].
    Song P; An ZM; Zhou XG; Li F; Wang LP; Zhao Q; Yu YP; Zhai YP
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Oct; 23(5):1357-61. PubMed ID: 26524037
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum immunoglobulin free light chains and their association with clinical phenotypes, serology and activity in patients with IgG4-related disease.
    Martín-Nares E; Saavedra-González V; Fagundo-Sierra R; Santinelli-Núñez BE; Romero-Maceda T; Calderón-Vasquez K; Hernandez-Molina G
    Sci Rep; 2021 Jan; 11(1):1832. PubMed ID: 33469111
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic value of involved/uninvolved free light chain ratio determined by Freelite and N Latex FLC assays for identification of high-risk smoldering myeloma patients.
    Henriot B; Rouger E; Rousseau C; Escoffre M; Sébillot M; Bendavid C; Minvielle S; Avet-Loiseau H; Decaux O; Moreau C
    Clin Chem Lab Med; 2019 Aug; 57(9):1397-1405. PubMed ID: 30973821
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Analysis of the relationship of heavy/light chain pairs of immunoglobulin (Hevylite) to the results of gel electrophoresis and nefelometric examination of serum proteins at the time of multiple myeloma diagnosis].
    Ščudla V; Lochman P; Pika T; Zapletalová J; Minařík J; Bačovský J
    Cas Lek Cesk; 2015; 154(6):292-302. PubMed ID: 26750626
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum Free Light Chain Assay: Shift Toward a Higher κ/λ Ratio.
    Rindlisbacher B; Schild C; Egger F; Bacher VU; Pabst T; Leichtle A; Andres M; Sédille-Mostafaie N
    J Appl Lab Med; 2020 Jan; 5(1):114-125. PubMed ID: 32445339
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum free light chain measurement aids the diagnosis of myeloma in patients with severe renal failure.
    Hutchison CA; Plant T; Drayson M; Cockwell P; Kountouri M; Basnayake K; Harding S; Bradwell AR; Mead G
    BMC Nephrol; 2008 Sep; 9():11. PubMed ID: 18808676
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quantitative assessment of serum free light chains in renal transplantation.
    Sánchez-Castañón M; Gago M; Fernandez-Fresnedo G; Gomez-Alamillo C; Ruiz-Criado J; Lopez-Hoyos M; Arias M
    Transplant Proc; 2010 Oct; 42(8):2861-3. PubMed ID: 20970552
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of the new Sebia free light chain assay using the AP22 ELITE instrument.
    Lutteri L; Aldenhoff MC; Cavalier E
    Clin Chim Acta; 2018 Dec; 487():161-167. PubMed ID: 30243748
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serum free light chains and post-transplant lymphoproliferative disorder in patients with renal transplant.
    Fernando RC; Rizzatti EG; Braga WM; Santos MG; de Oliveira MB; Pestana JO; Baiocchi OC; Colleoni GW
    Leuk Lymphoma; 2013 Oct; 54(10):2177-80. PubMed ID: 23398208
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development of a highly-sensitive multi-plex assay using monoclonal antibodies for the simultaneous measurement of kappa and lambda immunoglobulin free light chains in serum and urine.
    Campbell JP; Cobbold M; Wang Y; Goodall M; Bonney SL; Chamba A; Birtwistle J; Plant T; Afzal Z; Jefferis R; Drayson MT
    J Immunol Methods; 2013 May; 391(1-2):1-13. PubMed ID: 23388695
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.